Prevalence and determinants of impaired glucose metabolism in frail elderly patients: The Belgian elderly diabetes survey (BEDS)

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 2, 2005, Pages 241-247

  Hermans, Michel P ^a   Pepersack, Thierry M ^b   Godeaux, Lionel H ^c   Beyer, Ingo ^d   Turc, André P ^c  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c Menarini Benelux   (Belgium)

^d BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

AGED; AGING; ARTICLE; B LYMPHOCYTE; COHORT ANALYSIS; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEALTH SURVEY; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX RATIO; SOCIAL STATUS;

EID: 17144423294     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.2.241     Document Type: Article

References (63)

1. Jackson WP, Vinik AI, Joffe BI, Sacks A, Edelstein I. Prevalence of diabetes, glycosuria and related variables among a white population in Cape Town. S Afr Med J. 1969;43:1496-1499.
2. Agner E, Thorsteinsson B, Eriksen M. Impaired glucose tolerance and diabetes mellitus in elderly subjects. Diabetes Care. 1982;5:600-604.
3. Bolinder J, Ostman J, Arner P. Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue. Diabetes. 1983;32:959-964.
4. DeFronzo RA. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes. 1979;28:1095-1101.
5. Morley JE, Mooradian AD, Rosenthal MJ, Kaiser FE. Diabetes mellitus in elderly patients. Is it different? Am J Med. 1987;83:533-544.
6. Chen M, Bergman RN, Porte D Jr. Insulin resistance and beta-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab. 1988;67:951-957.
7. Jackson RA, Hawa MI, Roshania RD, Sim BM, DiSilvio L, Jaspan JB. Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes. 1988;37:119-129.
8. Jackson RA. Mechanisms of age-related glucose intolerance. Diabetes Care. 1990;13(Suppl 2):9-19.
9. Meneilly GS, Dawson K, Tessier D. Alterations in glucose metabolism in the elderly patient with diabetes. Diabetes Care. 1993;16:1241-1248.
10. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M. Seram proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia. 1995;38:1176-1182.
11. Scheen AJ, Sturis J, Polonsky KS, Van Cauter E. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia. 1996;39:564-572.
12. Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H. NIDDM in the elderly. Diabetes Care. 1996;19:1320-1325.
13. Tattersall RB. Diabetes in the elderly - a neglected area? Diabetologia. 1984;27:167-173.
14. Simmons D, Williams DR. Diabetes in the elderly: an under-diagnosed condition. Diabet Med. 1993;10:264-266.
15. Hiltunen L, Luukinen H, Koski K, Kivela SL. Prevalence of diabetes mellitus in an elderly Finnish population. Diabet Med. 1994;11:241-249.
16. Salive ME, Jones CA, Guralnik JM, Agodoa LY, Pahor M, Wallace RB. Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing. 1995;24:142-150.
17. Teuscher AU, Reinli K, Teuscher A, on behalf of the SENECA investigators. Glycaemia and insulinaemia in elderly European subjects (70-75 years). Diabet Med. 2001;18:150-153.
18. Wingard DL, Sinsheimer P, Barrett-Connor EL, McPhillips JB. Community-based study of prevalence of NIDDM in older adults. Diabetes Care. 1990;13(Suppl 2):3-8.
19. Rockwood K, Tan MH, Phillips S, McDowell I. Prevalence of diabetes mellitus in elderly people in Canada: report from the Canadian Study of Health and Aging. Age Ageing. 1998;27:573-577.
20. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1999;22:S5-S19.
21. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care. 1997;20:1859-1862.
22. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412-419.
23. Rudenski AS, Hadden DR, Atkinson AB, et al. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet Med. 1988;5:36-41.
24. Rudenski A, Matthews D, Levy J, Turner R. Understanding 'insulin resistance': both glucose resistance and insulin resistance are required to model human diabetes. Metabolism. 1991;40:908-917.
25. Levy J, Rudenski A, Burnett M, Knight R, Matthews D, Turner R. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1991;34:488-499.
26. Turner R, Levy J, Rudenski A, Hammersley M, Page R. Measurement of insulin resistance and beta-cell function: the HOMA and CIGMA approach. In: Belfiore F, Bergman R, Molinatti G, eds. Current Topics in Diabetes Research, vol. 12. Basel: Karger, 1993;66-75.
27. Hermans M, Levy JC, Morris RJ, Turner R. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia. 1999;42:678-687.
28. Levy J, Manley S, Sutton P, Camps I. Beta-cell function assessed by the fasting hyperglycaemic clamp: reproducibility compared with HOMA analysis from fasting values, and factors influencing variability. Diabetes. 1995;44:89A.
29. Haffner S, Gonzales C, Miettinen H, Kennedy E, Stern M. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138-1141.
30. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191-2192.
31. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes. Diabetes. 1999;48:1779-1786.
32. Greenfield S, Blanco DM, Elashoff RM, et al. Pattern of care related to age of breast cancer patients. JAMA. 1987;257:2766-2772.
33. Guigoz Y, Vellas B, Garry PJ. Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev. 1996;54:S59-S65.
34. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffee MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA 1963;185:914-919.
35. Blunt BA, Barrett Connor E, Wingard DL. Evaluation of fasting plasma glucose as screening test for NIDDM in older adults. Rancho Bernardo Study. Diabetes Care. 1991;14:989-993.
36. Wilson PW, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med. 1986;80:3-9.
37. Neil HAW, Gatling G, Mather HM, et al. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes. Diabet Med. 1987;4:539-543.
38. Kumar S, Prange A, Schulze J, Lettis S, Barnett AH. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients. Diabet Med. 1998;15:772-779.
39. Taverna MJ, Pacher N, Brazzo F, Slama G, Selam JL. Beta-cell function evaluated by HOMA as a predictor of secondary sulphonylurea failure in type 2 diabetes. Diabet Med. 2001;18:584-588.
40. Kishimoto H, Taniguchi A, Fukushima M, et al. Effect of short-term low-intensity exercise on insulin sensitivity, insulin secretion, and glucose and lipid metabolism in non-obese Japanese type 2 diabetic patients. Horm Metab Res. 2002;34:27-31.
41. Yokoyama H, Emoto M, Fujiwara S, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care. 2003;26:2426-2432.
42. Katsuki A, Sumida Y, Urakawa H, et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab. 2002;87:5332-5335.
43. Katsuki A, Sumida Y, Gabazza EC, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24:362-365.
44. Choi KM, Lee J, Kim YH, et al. Relation between insulin resistance and hematological parameters in elderly Koreans-Southwest Seoul (SWS) Study. Diabetes Res Clin Pract. 2003;60:205-212.
45. Josse RG, Chiasson JL, Ryan EA, et al. Acarbose in the treatment of elderly patients with type 2 diabetes. Diabetes Res Clin Pract. 2003;59:37-42.
46. Lichnovska R, Gwozdziewiczova S, Hrebicek J. Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects. Cardiovasc Diabetol. 2002;1:4.
47. Kim J, Choi S, Kong B, Oh Y, Shinn S. Insulin secretion and sensitivity during oral glucose tolerance test in Korean lean elderly women. J Korean Med Sci. 2001;16:592-597.
48. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett-Connor E. Insulin resistance precedes weight loss in adults without diabetes: the Rancho Bernardo Study. Am J Epidemiol. 2001;153:1199-1205.
49. Paolisso G, Tagliamonte MR, De Lucia D, et al. ACE gene polymorphism and insulin action in older subjects and healthy centenarians. J Am Geriatr Soc. 2001;49:610-614.
50. Ferrara CM, Goldberg AP. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Diabetes Care. 2001;24:245-249.
51. Bergman R, Phillips L, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. J Clin Invest. 1981;68:1456-1467.
52. Hansen IL, Cryer PE, Rizza RA. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects. Diabetes. 1985;34:751-755.
53. Turner RC, Rudenski AS, Holman RR, Matthews DR, O'Rahilly SP. Quantitative modelling of endocrine diseases as exemplified by diabetes. Clin Endocrinol (Oxf). 1987;26:107-116.
54. UKPDS Group. UK Prospective Diabetes Study V: characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet β-cell function. Diabet Med. 1988;5:444-448.
55. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667-687.
56. Eriksson J, Franssila Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989;321:337-343.
57. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism. 1989;38:767-772.
58. Groop L. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia. 1993;36:1326-1331.
59. Kahn S, Prigeon R, McCullogh D, et al. Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663-1672.
60. Turner R, Levy J, Rudenski A, Hammersley M, Page R. Measurement of insulin resistance and beta-cell function: the HOMA and CIGMA approach. In: Belfiore F, Bergman R, Molinatti G, eds. Current Topics in Diabetes Research, vol. 12. Basel: Karger: 1993;66-75.
61. UK Prospective Diabetes Study 16: Overview of six years' therapy of type 2 diabetes: a progressive disease. Diabetes. 1995;44:1249-1258.
62. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 1996;19:1018-1030.
63. Mooradian AD, Osterweil D, Petrasek D, Morley JE. Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management. J Am Geriatr Soc. 1988;36:391-396.